This commentary (2024) provides an evidence-informed assessment of psychedelic research for treating depression. It discusses the shift in media reporting from overstating the risks to overly positive hype and emphasizes the need for clear science communication to set public expectations and inform policy decisions accurately.
- Published
- Journal
- Psychoactives
- Authors
- Meling, D., Ehrenkra, R., Nayak, S., Aich, H. D., Funk, X., Van Elk, M., Graziosi, M., Bauer, P. R., Scheidegger, M., Yaden, D. B.